Skip to Main Content

Author Details

Randy A Albrecht
Icahn School of Medicine at Mount Sinai
2001
125
51
Trey Ideker (CM4AI)
PMIDPaper TitleJournal TitlePublished Year
36271493Evaluation and validation of an RT-PCR assay for specific detection of monkeypox virus (MPXV).J Med Virol2023
37758692Proteomic and genetic analyses of influenza A viruses identify pan-viral host targets.Nat Commun2023
37166327Field Research Is Essential to Counter Virological Threats.J Virol2023
36572153NS2 is a key determinant of compatibility in reassortant avian influenza virus with heterologous H7N9-derived NS segment.Virus Res2023
36927408Phylogenetic landscape of Monkeypox Virus (MPV) during the early outbreak in New York City, 2022.Emerg Microbes Infect2023
34669512Functional Effects of Cardiomyocyte Injury in COVID-19.J Virol2022
35583364Mutation L319Q in the PB1 Polymerase Subunit Improves Attenuation of a Candidate Live-Attenuated Influenza A Virus Vaccine.Microbiol Spectr2022
35357204Detection of Velogenic Avian Paramyxoviruses in Rock Doves in New York City, New York.Microbiol Spectr2022
35979918A variant NS1 protein from H5N2 avian influenza virus suppresses PKR activation and promotes replication and virulence in mammals.Emerg Microbes Infect2022
35186917Profiling Selective Packaging of Host RNA and Viral RNA Modification in SARS-CoV-2 Viral Preparations.Front Cell Dev Biol2022
35247306Limited extent and consequences of pancreatic SARS-CoV-2 infection.Cell Rep2022
35150638Mutations in SARS-CoV-2 variants of concern link to increased spike cleavage and virus transmission.Cell Host Microbe2022
35025969Advances and gaps in SARS-CoV-2 infection models.PLoS Pathog2022
33440898Chimeric Hemagglutinin-Based Live-Attenuated Vaccines Confer Durable Protective Immunity against Influenza A Viruses in a Preclinical Ferret Model.Vaccines (Basel)2021
33795830Pathophysiology of SARS-CoV-2: the Mount Sinai COVID-19 autopsy experience.Mod Pathol2021
33564793Longitudinal Metabolomics of Human Plasma Reveals Robust Prognostic Markers of COVID-19 Disease Severity.medRxiv2021
33836156TOP1 inhibition therapy protects against SARS-CoV-2-induced lethal inflammation.Cell2021
34556855Restriction factor compendium for influenza A virus reveals a mechanism for evasion of autophagy.Nat Microbiol2021
34696339Interaction between NS1 and Cellular MAVS Contributes to NS1 Mitochondria Targeting.Viruses2021
34623911Tox2 is required for the maintenance of GC T<sub>FH</sub> cells and the generation of memory T<sub>FH</sub> cells.Sci Adv2021
33941899A human-airway-on-a-chip for the rapid identification of candidate antiviral therapeutics and prophylactics.Nat Biomed Eng2021
33961839Tissue-based SARS-CoV-2 detection in fatal COVID-19 infections: Sustained direct viral-induced damage is not necessary to drive disease progression.Hum Pathol2021
34308390Longitudinal metabolomics of human plasma reveals prognostic markers of COVID-19 disease severity.Cell Rep Med2021
33252647Real-Time Investigation of a Large Nosocomial Influenza A Outbreak Informed by Genomic Epidemiology.Clin Infect Dis2021
31630990Immunogenicity of chimeric haemagglutinin-based, universal influenza virus vaccine candidates: interim results of a randomised, placebo-controlled, phase 1 clinical trial.Lancet Infect Dis2020
31776276Viral Determinants in H5N1 Influenza A Virus Enable Productive Infection of HeLa Cells.J Virol2020
33310880Mass Cytometry Defines Virus-Specific CD4<sup>+</sup> T Cells in Influenza Vaccination.Immunohorizons2020
33299999Topoisomerase 1 inhibition therapy protects against SARS-CoV-2-induced inflammation and death in animal models.bioRxiv2020
33348607A Newcastle Disease Virus (NDV) Expressing a Membrane-Anchored Spike as a Cost-Effective Inactivated SARS-CoV-2 Vaccine.Vaccines (Basel)2020
32766572A Newcastle disease virus (NDV) expressing membrane-anchored spike as a cost-effective inactivated SARS-CoV-2 vaccine.bioRxiv2020
32707573Discovery of SARS-CoV-2 antiviral drugs through large-scale compound repurposing.Nature2020
32585083An In Vitro Microneutralization Assay for SARS-CoV-2 Serology and Drug Screening.Curr Protoc Microbiol2020
32416070Imbalanced Host Response to SARS-CoV-2 Drives Development of COVID-19.Cell2020
32439901Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection.Nat Commun2020
32546784Author Correction: Microbiome disturbance and resilience dynamics of the upper respiratory tract during influenza A virus infection.Nat Commun2020
30496437Diminished B-Cell Response After Repeat Influenza Vaccination.J Infect Dis2019
31839997Pandemic influenza virus vaccines boost hemagglutinin stalk-specific antibody responses in primed adult and pediatric cohorts.NPJ Vaccines2019
31497029Vaccination With Viral Vectors Expressing Chimeric Hemagglutinin, NP and M1 Antigens Protects Ferrets Against Influenza Virus Challenge.Front Immunol2019
31375585Innate Immune Response to Influenza Virus at Single-Cell Resolution in Human Epithelial Cells Revealed Paracrine Induction of Interferon Lambda 1.J Virol2019
31043530Host-Specific NS5 Ubiquitination Determines Yellow Fever Virus Tropism.J Virol2019
31105689Sequential Immunization With Live-Attenuated Chimeric Hemagglutinin-Based Vaccines Confers Heterosubtypic Immunity Against Influenza A Viruses in a Preclinical Ferret Model.Front Immunol2019
30146161Transcription Elongation Can Affect Genome 3D Structure.Cell2018
30188868Antigenic sites in influenza H1 hemagglutinin display species-specific immunodominance.J Clin Invest2018
29991715A multifunctional human monoclonal neutralizing antibody that targets a unique conserved epitope on influenza HA.Nat Commun2018
30018107Moving Forward: Recent Developments for the Ferret Biomedical Research Model.mBio2018
30151589Analyses of Cellular Immune Responses in Ferrets Following Influenza Virus Infection.Methods Mol Biol2018
30151588Assessment of Influenza Virus Hemagglutinin Stalk-Specific Antibody Responses.Methods Mol Biol2018
30044403A Live-Attenuated Prime, Inactivated Boost Vaccination Strategy with Chimeric Hemagglutinin-Based Universal Influenza Virus Vaccines Provides Protection in Ferrets: A Confirmatory Study.Vaccines (Basel)2018
30177761Influenza virus infection causes global RNAPII termination defects.Nat Struct Mol Biol2018
28783704Constitutive resistance to viral infection in human CD141<sup>+</sup> dendritic cells.Sci Immunol2017
  • 1 - 50 of 125

Recommended Authors

Sebastian Giese
Institute of Virology, Freiburg University Medical Center, University of Freiburg
Career Start Year 2012
Number of shared co-authors 9
Hongjie Xia
University of Texas Medical Branch
Career Start Year 2012
Number of shared co-authors 3
Brook E Heaton
Duke University School of Medicine
Career Start Year 2012
Number of shared co-authors 7
James Zengel
Stanford University School of Medicine
Career Start Year 2010
Number of shared co-authors 10
Lynda Coughlan
University of Maryland
Career Start Year 2009
Number of shared co-authors 20
Jennifer Tisoncik-Go
Center for Innate Immunity and Immune Disease, University of Washington
Career Start Year 2009
Number of shared co-authors 12
Vineet D Menachery
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 17
Hans-Heinrich Hoffmann
The Rockefeller University
Career Start Year 2008
Number of shared co-authors 18
Alexander N Freiberg
University of Texas Medical Branch
Career Start Year 2008
Number of shared co-authors 12
Yasuko Hatta
FluGen Inc.
Career Start Year 2007
Number of shared co-authors 5
Preeti Bharaj
University of Texas Medical Branch
Career Start Year 2007
Number of shared co-authors 10
Laurence Josset
Institut des Agents Infectieux, Infective Agents Institute, North Hospital Network
Career Start Year 2007
Number of shared co-authors 13
Colm Atkins
Rutgers University
Career Start Year 2007
Number of shared co-authors 7
Qiyun Zhu
Biodesign Center for Fundamental and Applied Microbiomics, Arizona State University
Career Start Year 2007
Number of shared co-authors 1
Mila B Ortigoza
NYU Grossman School of Medicine
Career Start Year 2006
Number of shared co-authors 14
Amie J Eisfeld
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 2006
Number of shared co-authors 16
Shufang Fan
Influenza Research Institute, University of Wisconsin
Career Start Year 2006
Number of shared co-authors 16
Amber M Smith
University of California san francisco
Career Start Year 2006
Number of shared co-authors 33
Chengjun Li
Harbin Veterinary Research Institute
Career Start Year 2005
Number of shared co-authors 16
Sudhakar Agnihothram
National Center for Toxicological Research
Career Start Year 2005
Number of shared co-authors 12
Man-Seong Park
Korea University College of Medicine
Career Start Year 2001
Number of shared co-authors 14
Timothy H Burgess
Infectious Disease Clinical Research Program, Uniformed Services University
Career Start Year 2000
Number of shared co-authors 2
Masato Hatta
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 2000
Number of shared co-authors 16
Sonja M Best
National Institute of Allergy and Infectious Diseases, National Institutes of Health
Career Start Year 1998
Number of shared co-authors 14
Gary P Kobinger
University of Texas Medical Branch
Career Start Year 1997
Number of shared co-authors 13
Gabriele Neumann
Influenza Research Institute, University of Wisconsin-Madison
Career Start Year 1993
Number of shared co-authors 21
Boyd L Yount
University of North Carolina at Chapel Hill
Career Start Year 1993
Number of shared co-authors 18
Ted M Ross
Center for Vaccines and Immunology, University of Georgia
Career Start Year 1991
Number of shared co-authors 21
Bart L Haagmans
Erasmus Medical Center
Career Start Year 1986
Number of shared co-authors 11
Yoshihiro Kawaoka
Influenza Research Institute, University of Wisconsin
Career Start Year 1979
Number of shared co-authors 33

Collaborators

Adolfo Garc??a-Sastre
Icahn School of Medicine at Mount Sinai
Co-authored papers 95
Peter Palese
Icahn School of Medicine at Mount Sinai
Co-authored papers 21
Rong Hai
University of California riverside
Co-authored papers 10
Ignacio Mena
Icahn School of Medicine at Mount Sinai
Co-authored papers 9
Michael Schotsaert
Icahn School of Medicine at Mount Sinai
Co-authored papers 9
Juergen A Richt
College of Veterinary Medicine, Kansas State University
Co-authored papers 8
Sumit K Chanda
The Scripps Research Institute
Co-authored papers 8
Terrence M Tumpey
Centers for Disease Control and Prevention.
Co-authored papers 8
Viviana Simon
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Raveen Rathnasinghe
Icahn School of Medicine at Mount Sinai New York
Co-authored papers 7
Robert Sebra
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Kris M White
Quantitative Biosciences Institute (QBI) Coronavirus Research Group (QCRG)
Co-authored papers 7
Stuart C Sealfon
Icahn School of Medicine at Mount Sinai
Co-authored papers 7
Ivan Marazzi
Center for Epigenetics and Metabolism, University of California irvine
Co-authored papers 6
Lars Pache
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 6
Luis Martinez-Sobrido
Texas Biomedical Research Institute
Co-authored papers 6
Boris M Hartmann
Institute of Veterinary Disease Control
Co-authored papers 6
Lisa Miorin
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Benjamin R tenOever
NYU Grossman School of Medicine
Co-authored papers 6
Christopher Benner
Michigan State University College of Human Medicine
Co-authored papers 6
Harm van Bakel
Icahn School of Medicine at Mount Sinai
Co-authored papers 6
Nevan J Krogan (CM4AI)
University of California San Francisco
Co-authored papers 6
Teresa Aydillo
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Ana S Gonzalez-Reiche
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Emilia Mia Sordillo
Icahn School of Medicine at Mount Sinai
Co-authored papers 5
Balaji Manicassamy
University of Iowa
Co-authored papers 5
Michael G Katze
University of Washington
Co-authored papers 5
Laura Martin-Sancho
The Scripps Research Institute
Co-authored papers 4
Elena Zaslavsky
Icahn School of Medicine at Mount Sinai
Co-authored papers 4
Paul D De Jesus
Sanford Burnham Prebys Medical Discovery Institute
Co-authored papers 4
Release 1.2